Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
Report ID | 105189 |
Drug Identification Number | 02139510 |
Brand name | SODIUM CHLORIDE INJECTION, USP |
Common or Proper name | Sodium Chloride Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 234MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 100mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-01-31 |
Estimated end date | 2020-04-20 |
Actual end date | 2020-03-24 |
Shortage status | Resolved |
Updated date | 2020-03-25 |
Company comments | Our Sodium Chloride Injection, USP PBP Vial 200mL will be available for substitution, and allocations of Sodium Chloride Injection 200mL vial have been increased to cover the Sodium Chloride 100mL demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-03-25 | English | Compare |
v4 | 2020-03-24 | French | Compare |
v3 | 2020-03-24 | English | Compare |
v2 | 2020-02-03 | French | Compare |
v1 | 2020-02-03 | English | Compare |
Showing 1 to 5 of 5